PedAM
Pediatric Disease Annotations & Medicines
| Disease | parathyroid carcinoma |
| Phenotype | C0020437|hypercalcemia |
| Sentences | 4 |
| PubMedID- 20382129 | The second approved use of cinacalcet is for treating hypercalcemia in patients with inoperable parathyroid carcinoma. |
| PubMedID- 25667369 | Review of the literature revealed 4 case reports and a letter to the editor, all of which reported the successful treatment of resistant hypercalcemia associated with parathyroid carcinoma. |
| PubMedID- 21461394 | Since the approval of cinacalcet hcl for the therapy of secondary hyperparathyroidism (shpt) and hypercalcemia due to parathyroid carcinoma in 2004, calcimimetic therapy has become daily routine especially for clinical nephrologists worldwide. |
| PubMedID- 22363762 | The average monthly increase in patients for the fda-approved orphan indication (hypercalcemia in patients with parathyroid carcinoma) was 0.03 (95% ci: 0.01–0.05). |
Page: 1